Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

clinical research

  • Home
  • clinical research
Synergistic Protection of Pancreatic Beta Cells: GLP1-E2 and Low-Dose Anti-CD3 Combination Therapy in Autoimmune Diabetes
Posted inClinical Updates Diabetes & Endocrinology news

Synergistic Protection of Pancreatic Beta Cells: GLP1-E2 and Low-Dose Anti-CD3 Combination Therapy in Autoimmune Diabetes

Posted by MedXY By MedXY 05/20/2026
Recent studies demonstrate that combining the beta-cell-targeted conjugate GLP1-E2 with low-dose anti-CD3 therapy significantly delays type 1 diabetes onset by simultaneously reducing immune infiltration and mitigating beta-cell cellular stress.
Read More
Motor Vehicle Accidents vs. Falls: Does the Mechanism of TBI Predict Long-Term Recovery?
Posted inEmergency Medicine Neurology news

Motor Vehicle Accidents vs. Falls: Does the Mechanism of TBI Predict Long-Term Recovery?

Posted by MedXY By MedXY 03/11/2026
A large-scale longitudinal study reveals that motor vehicle accidents cause significantly worse acute traumatic brain injury outcomes compared to falls. However, by one year post-injury, disability levels and community participation converge, suggesting different recovery trajectories based on the mechanism of injury.
Read More
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction
Posted inCardiology Clinical Updates news Specialties

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

Posted by MedXY By MedXY 08/17/2025
This study explores the Left Atrial Coupling Index as a key predictor in heart failure patients with preserved ejection fraction.
Read More
Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy

Posted by MedXY By MedXY 07/29/2025
A new study reveals combining tirzepatide and hormone therapy significantly boosts weight loss in postmenopausal women, offering a promising approach to managing obesity-related health risks.
Read More
Unveiling the Potential of Anti-Aging Drugs: A New Horizon in Longevity Research
Posted inCardiology news Specialties

Unveiling the Potential of Anti-Aging Drugs: A New Horizon in Longevity Research

Posted by MedXY By MedXY 07/28/2025
Explore the promising world of anti-aging drugs and their potential to extend human lifespan, focusing on current research and challenges.
Read More
  • Digital Vestibular Rehabilitation After Acute Vertigo: What a Negative Superiority Trial Means
  • Restoring Cortisol Rhythm May Be Key to Recovery After Cushing Syndrome
  • Long-term Follow-up of Type 1 Diabetes Immunotherapy Trials Finds Reassuring Safety Signals
  • Long-Term Safety Signals Remain Reassuring in Type 1 Diabetes Immunotherapy Follow-up
  • Mitochondrial Rescue in HFpEF: Elamipretide Restores Skeletal Muscle Performance in a Rat Model
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health quality of life randomized clinical trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in